Edarbi Approved for Treatment of Hypertension
New Drugs , News / September 20, 2016

On February 25, 2011 the FDA approved Edarbi tablets (azilsartan medoxomil) for the treatment of hypertension in adults. Data released from clinical studies showed Edarbi to be more effective in lowering 24-hour blood pressure compared with two ot...

Skip to toolbar